Evidence map›Paper›PMID 39263942›Full record

ArticleImmunotherapy2024

Profiling of autoantibodies in the sera of glioblastoma patients.

Johannes Low Jun Wei, Ammar Akram Kamarudin, Bee Hong Soon, Kamalanathan Palaniandy, Azizi Abu Bakar, Jegan Thanabalan, Ramesh Kumar Athi Kumar, Ainul Syahrilfazli Jaafar, Sanmugarajah Paramasvaran, Farizal Fadzil and 1 more

Abstract read
In one paragraph

Article in Immunotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Johannes Low Jun WeiUKM Medical Molecular Biology Institute (UMBI), Universiti Kebangsaan Malaysia (UKM), Kuala Lumpur, Malaysia.
Ammar Akram KamarudinUKM Medical Molecular Biology Institute (UMBI), Universiti Kebangsaan Malaysia (UKM), Kuala Lumpur, Malaysia.
Bee Hong SoonNeurosurgery Unit, Department of Surgery, Faculty of Medicine, Universiti Kebangsaan Malaysia (UKM), Kuala Lumpur, Malaysia.
Kamalanathan PalaniandyNeurosurgery Unit, Department of Surgery, Faculty of Medicine, Universiti Kebangsaan Malaysia (UKM), Kuala Lumpur, Malaysia.
Azizi Abu BakarNeurosurgery Unit, Department of Surgery, Faculty of Medicine, Universiti Kebangsaan Malaysia (UKM), Kuala Lumpur, Malaysia.
Jegan ThanabalanNeurosurgery Unit, Department of Surgery, Faculty of Medicine, Universiti Kebangsaan Malaysia (UKM), Kuala Lumpur, Malaysia.
Ramesh Kumar Athi KumarNeurosurgery Unit, Department of Surgery, Faculty of Medicine, Universiti Kebangsaan Malaysia (UKM), Kuala Lumpur, Malaysia.
Ainul Syahrilfazli JaafarNeurosurgery Unit, Department of Surgery, Faculty of Medicine, Universiti Kebangsaan Malaysia (UKM), Kuala Lumpur, Malaysia.
Sanmugarajah ParamasvaranNeurosurgery Unit, Department of Surgery, Faculty of Medicine, Universiti Kebangsaan Malaysia (UKM), Kuala Lumpur, Malaysia.
Farizal FadzilNeurosurgery Unit, Department of Surgery, Faculty of Medicine, Universiti Kebangsaan Malaysia (UKM), Kuala Lumpur, Malaysia.
Nadiah AbuUKM Medical Molecular Biology Institute (UMBI), Universiti Kebangsaan Malaysia (UKM), Kuala Lumpur, Malaysia.

Funding

HICOE grant under Ministry of Higher Education JJ-2021-003
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AutoantibodiesGlioblastomaAdultAgedBiomarkers, TumorBrain NeoplasmsFemaleHSP90 Heat-Shock ProteinsHumansMaleMiddle AgedAutoantibodiesBiomarkers, TumorHSP90 Heat-Shock ProteinsautoantibodiesglioblastomaKREXliquid biopsymicroarray

Identifiers

PMID39263942
PMCPMC11492691

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.